Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

93 Percent of Nucleoside-Naive Chronic Hepatitis B e-Antigen (HBeAg)-Negative Patients Achieved Undetectable Viral Load by Week 48 of Re-Treatment

PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company today announced data from a cohort of nucleoside-naive HBeAg-negative chronic hepatitis B patients (ETV-027/901, n=99). These data showed that patients who experienced recurrent levels of hepatitis B virus in the blood after interruption of treatment with BARACLUDE(R) (entecavir) achieved viral suppression and liver enzyme (ALT) normalization when re- treated for 48 weeks with BARACLUDE. The study results were presented at the 42nd Annual Meeting of the European Association for the Study of Liver Diseases (EASL) in Barcelona, Spain.

In this cohort, 93 percent of patients who were re-treated with BARACLUDE had undetectable viral load - the level of the hepatitis B virus in the blood - (HBV DNA <300 copies/mL, measured by a common assay - polymerase chain reaction or PCR) and 83 percent achieved liver enzyme normalization (ALT less than or equal to 1xULN) after 48 weeks of therapy.

"This study showed that when treated again with BARACLUDE for 48 weeks, patients achieved responses similar to those seen prior to treatment interruption, with safety results consistent with previously reported experience," said Hakan Senturk, MD, of the Ist.Univ.Cerrahpasa Tip Fak, Istanbul, Turkey.

No deaths or treatment discontinuations due to adverse events were reported in this cohort. The most common adverse events occurring in greater than 10 percent of patients were abdominal pain, fatigue, upper respiratory tract infection, nasopharyngitis, increased ALT, arthralgia, and headache.

About the Nucleoside-Naive HBeAg-Negative BARACLUDE(R) (entecavir) Re- Treatment Cohort

This analysis evaluated BARACLUDE(R) (entecavir) in nucleoside-naive chronic HBeAg-negative patie
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
(Date:8/21/2014)...  Aptuit LLC announces that Aptuit SSCI, located ... has enhanced its capabilities in the areas of ... molecules, including biologic drugs, metabolites, and polymers, through ... spectrometer. In making the announcement, Dr. ... expanded large molecule capability enhances our early development ...
(Date:8/21/2014)...  eRelevance Corporation ( www.erelevancecorp.com ), a progressive ... has completed integration with Nextech, a popular Electronic ... Dermatology practices. "Integration allows our service ... using Nextech," stated Bob Fabbio , co-founder ... the EMR we are able to automatically target ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... Corporation, a leading provider of powered toilet lifts for ... today a new white paper that details a return-on-investment ... financial impact of using powered toilet lifts in support ... The white paper was introduced at the 12th Annual ...
... -- Global Information Inc. is excited to announce ... 8th Annual World Health Care Congress - Europe ... healthcare systems may be diverse, but the all share many ... health systems across the entire world, and many nations are ...
Cached Medicine Technology:New White Paper Offers Model for Measuring Financial Impact of Reducing Toileting-Related Falls in Healthcare Facilities 28th Annual World Health Care Congress Set for Amsterdam, Spring 2012 2
(Date:8/22/2014)... children have a higher-than-normal risk of developing food allergies, a ... in four U.S. cities -- Baltimore, Boston, New York and ... that at least 10 percent of them developed an allergy ... most common types of food allergies were included in the ... allergies may be even higher, the researchers said. Overall, ...
(Date:8/22/2014)... severe disabilities and multiple chronic conditions are screened for ... or no chronic conditions, a new study has found. ... with moderate disabilities or women with only one chronic ... with the Li Ka Shing Knowledge Institute of St. ... often have other measures of social vulnerability, such as ...
(Date:8/22/2014)... 22, 2014 Key West Health & ... revealed their much anticipated study results of the 12 ... and released an accompanying infographic on their website. It ... have a major impact on the skin and contribute ... more. , When asked how they determined the results, ...
(Date:8/22/2014)... Until now, those with leg or foot ... to keep mobile. Thanks to an inventor from Suffolk, Va., ... , He developed a prototype for the patent-pending SUPPORT AID ... foot but provide comfort and reduce pain for those using ... is also convenient and easy to install on the crutch ...
(Date:8/22/2014)... difficulties, fainting. Each year approx. 265,000 Danes are acutely ... New research from Aarhus University and Aarhus University Hospital ... as every fourth patient are sent home again ... led to the acute hospitalisation., "Naturally, there is no ... hospital disprove that there is a serious illness. So ...
Breaking Medicine News(10 mins):Health News:Food Allergies More Common Among Inner City Kids, Study Finds 2Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Key West Health & Beauty Announces The 12 Best & Worst U.S. Cities For Skin Study 2Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Many patients are discharged without a diagnosis 2
... as likely as white patients to receive therapy, study ... patients with heart disease are only half as likely ... a Duke University Medical Center study. , "This is ... associated with a 2- to 4-fold increase in the ...
... not rated high in survey , , WEDNESDAY, Oct. 29 ... not satisfied with their care, Harvard researchers report. , ... hospitals were found wanting in key areas such as ... of patients gave low ratings to pain management, and ...
... to Match Physicians with Hiring Organizations to Save You Time ... ... California (PRWEB) October 29, 2008 -- MedMatcher, Inc. today announced ... provide physicians a simple solution to find the perfect physician ...
... housing opportunities ... statewide, ... and support services professionals gathered,in Duluth for Heading Home Minnesota,s Marking ... housing,opportunities with support services for Minnesota individuals and families,who are homeless., ...
... has announced the,launch of an ongoing series of ... for managing the changing healthcare,landscape. The first in ... Pharmacy, will convene Wednesday evening,October 29, at the ... run,through Thursday, October 30, 2008., This invitation-only ...
... or not, we all experience memory errors from time to ... result of having too many other things to remember or ... have indicated that a specific type of false memory known ... a mistake that we often make when recalling a view ...
Cached Medicine News:Health News:Black Heart Patients Treated Less for Depression 2Health News:U.S. Hospitals Lag in Patient Satisfaction 2Health News:U.S. Hospitals Lag in Patient Satisfaction 3Health News:eMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 2Health News:eMatchPhysicians.com Launches to Provide Physicians and Hiring Organizations with a Better Way to Find the Perfect Physician Job 3Health News:Minnesota Reaches Milestone in Goal to End Homelessness 2Health News:NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 2Health News:NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders 3Health News:Our cheatin' brain: The brain's clever way of showing us the world as a whole 2
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
OES Pro Optical Urethrotome...
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
... line combines market-leading optical ... durable hardware. The color-coded ... robust, ergonomic design and ... on Stryker endoscopes. The ...
Medicine Products: